Bioharvest Sciences Inc.

BHST Biotech & pharma

Develops dietary supplements and food ingredients for human consumption.

Dec 2025Revenue $34.5M/yrExpenses $40.1M/yr
No trendCash runway ≈ 2.4 years from Dec 2025
Figures by year

When will Bioharvest Sciences be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $34.5M and expenses $40.1M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$34.5M$40.1M−$5.58M
Dec 2024$25.2M$32.2M−$6.99M
Dec 2023$12.7M$22.6M−$9.97M